查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1786980

红生物科技的全球市场，规模，占有率，趋势，产业分析报告:各产品，各最终用途，各地区 - 市场预测(2025年～2034年)

Red Biotechnology Market Size, Share, Trends, Industry Analysis Report By Product (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Proteins, Vaccines, Cell-Based Immunotherapy Products), By End Use, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，预计到 2034 年，全球红色生物技术市场规模将达到 14,157.7 亿美元。本报告深入分析了当前的市场动态，并分析了未来的市场成长。

红色生物技术是生物技术的一个分支，专注于改善人类健康的医疗和製药应用。它利用生物体、细胞和生物过程来开发治疗、诊断和疾病预防方法。该领域为复杂的健康挑战提供创新解决方案，并在现代医学的发展中发挥关键作用。

红色生物技术的主要应用之一是药物开发。研究人员正在利用基因工程生产胰岛素、疫苗和单株抗体等生物製药。重组 DNA 技术使得利用基因改造细菌生产人类胰岛素成为可能。同样，mRNA疫苗和疗法（例如为COVID-19开发的疫苗和疗法）表明，红色生物技术能够快速应对疫情。

红色生物技术还能增强诊断工具和技术。聚合酶炼式反应 (PCR) 和新一代定序 (NGS) 等先进技术能够及早、准确地检测癌症和传染病等疾病。此外，红色生物技术支持疫苗的开发，以预防B肝、HPV和流感等疾病。合成生物学加速了疫苗设计，生物反应器促进了疫苗的大规模生产。在癌症治疗领域，红色生物技术的创新免疫疗法利用免疫系统来靶向肿瘤，CAR-T细胞等疗法已在某些血癌治疗中取得显着成功。

红色生物技术市场报告重点

按产品类型划分，广泛用于治疗癌症、自体免疫疾病和传染病的单株抗体预计将在2024年占市场收入的49.13%。

按最终用途划分，製药和生物技术公司在推动生物製剂和先进疗法的创新、临床开发和商业化方面发挥了重要作用，在2024年占了相当大的收入占有率。

2024年，北美占了全球红色生物技术市场的34.16%。这种主导地位归因于完善的医疗基础设施、高额的研发投入以及癌症、糖尿病和心血管疾病等慢性疾病的日益普及。

得益于全民健保体系、政府和欧盟的大力资助以及对再生医学和生物相似药的重视，预计到2034年，欧洲市场将占相当大的占有率。

受医疗支出成长、中产阶级壮大以及传染性和非传染性疾病负担加重的推动，亚太市场预计在2025年至2034年间的复合年增长率将达到15.34%。

红色生物技术市场的全球领导公司包括安进、阿斯特捷利康、百健、百时美施贵宝、罗氏製药、吉利德科学、默克、Mavrix Bio、辉瑞、再生元和武田製药。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 全球红生物科技市场洞察

  • 市场概述
  • 红生物科技市场动态
    • 促进因素和机会
      • 个人化医疗需求不断成长
      • 癌症研究投资不断增加
    • 限制因素与挑战
      • 成本高昂
  • PESTEL分析
  • 红生物科技市场趋势
  • 价值链分析

第5章 全球红生物科技市场:各产品

  • 主要调查结果
  • 简介
  • 单株抗体
  • 多株抗体
  • 重组蛋白品质
  • 疫苗
  • 细胞为基础的免疫疗法产品
  • 基因治疗产品
  • 细胞治疗产品
  • 组织工程产品
  • 干细胞
  • 细胞培养
  • 病毒载体
  • 酵素
  • 套件和试剂
  • 动物模式
  • 分子诊断
  • 其他

第6章 全球红生物科技市场:各最终用途

  • 主要调查结果
  • 简介
  • 学术研究机关
  • CMO和CRO
  • 製药·生物科技企业
  • 其他

第7章 全球红生物科技市场:各地区

  • 主要调查结果
  • 简介
    • 红生物科技市场评估:各地区，2020～2034年
  • 北美
    • 北美:各产品，2020～2034年
    • 北美:各最终用途，2020～2034年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各产品，2020～2034年
    • 欧洲:各最终用途，2020～2034年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:各产品，2020～2034年
    • 亚太地区:各最终用途，2020～2034年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:各产品，2020～2034年
    • 中东·非洲:各最终用途，2020～2034年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东·非洲
  • 南美
    • 南美:各产品，2020～2034年
    • 南美:各最终用途，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第8章 竞争情形

  • 事业扩大·收购分析
    • 事业扩大
    • 收购
  • 联盟/合作/协定/公开

第9章 企业简介

  • AstraZeneca
  • Amgen Inc.
  • Merck & Co
  • Bristol-Myers Squibb
  • Pfizer
  • Biogen
  • F. Hoffmann-La Roche Ltd
  • Gilead Sciences, Inc.
  • MavriX Bio
  • Regeneron Pharmaceuticals, Inc.
  • Takeda Pharmaceutical Company
Product Code: PM5961

The red biotechnology market size is expected to reach USD 1,415.77 billion by 2034, according to a new study by Polaris Market Research. The report "Red Biotechnology Market Size, Share, Trends, Industry Analysis Report By Product (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Proteins, Vaccines, Cell-Based Immunotherapy Products), By End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Red biotechnology, a branch of biotechnology, focuses on medical and pharmaceutical applications to improve human health. It involves the use of living organisms, cells, and biological processes to develop therapies, diagnostics, and preventive measures for diseases. This field plays a crucial role in advancing modern medicine, offering innovative solutions for complex health challenges.

One of the primary applications of red biotechnology is in the development of drugs. Researchers produce biopharmaceuticals such as insulin, vaccines, and monoclonal antibodies by leveraging genetic engineering. Recombinant DNA technology enables the production of human insulin using genetically modified bacteria. Similarly, mRNA vaccines and therapeutics, such as those developed for COVID-19, demonstrate how red biotechnology enables rapid responses to pandemics.

Red biotechnology also enhances diagnostic tools and techniques. Advanced techniques, such as polymerase chain reaction (PCR) and next-generation sequencing (NGS), enable the early and accurate detection of diseases, including cancers and infectious diseases. Furthermore, red biotechnology supports vaccine development, which prevents diseases such as hepatitis B, HPV, and influenza. Synthetic biology accelerates vaccine design, while bioreactors facilitate large-scale production. In cancer treatment, immunotherapy, a red biotechnology innovation, harnesses the immune system to target tumors, with therapies such as CAR-T cells showing remarkable success in certain blood cancers.

Red Biotechnology Market Report Highlights

In terms of product, the monoclonal antibodies segment accounted for 49.13% of market revenue share in 2024 due to their widespread adoption in the treatment of cancer, autoimmune disorders, and infectious diseases.

Based on end use, the pharmaceutical & biotechnology companies segment accounted for a major revenue share in 2024 due to their role in driving innovation, clinical development, and commercialization of biologics and advanced therapies.

North America accounted for a 34.16% share of the global red biotechnology market in 2024. This dominance is attributed to established healthcare infrastructure, high R&D investments, and a growing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders.

The market in Europe is projected to hold a substantial share by 2034 due to universal healthcare systems, strong government and EU funding, and a focus on regenerative medicine and biosimilars.

The market in Asia Pacific is projected to register a CAGR of 15.34% from 2025 to 2034, owing to increasing healthcare spending, a rising middle class, and a high burden of infectious and noncommunicable diseases.

A few global key players in the red biotechnology market include Amgen Inc.; AstraZeneca; Biogen; Bristol-Myers Squibb Company; F. Hoffmann-La Roche Ltd; Gilead Sciences, Inc.; Merck KGaA; MavriX Bio; Pfizer Inc.; Regeneron Pharmaceuticals, Inc.; and Takeda Pharmaceutical Company Limited.

Polaris Market Research has segmented the red biotechnology market report on the basis of product, end use, and region:

By Product Outlook (Revenue, USD Billion, 2020-2034)

Monoclonal Antibodies

Polyclonal Antibodies

Recombinant Proteins

Vaccines

Cell-Based Immunotherapy Products

Gene Therapy Products

Cell Therapy Products

Tissue-Engineered Products

Stem Cells

Cell Culture

Viral Vector

Enzymes

Kits and Reagents

Animal Models

Molecular Diagnostics

Other

By End Use Outlook (Revenue, USD Billion, 2020-2034)

Academic Research Institutes

CMOs & CROs

Pharmaceutical & Biotechnology Companies

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Red Biotechnology Market Insights

  • 4.1. Red Biotechnology Market - Market Snapshot
  • 4.2. Red Biotechnology Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Demand for Personalized Medicine
      • 4.2.1.2. Rising Investment in Cancer Research
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Red Biotechnology Market Trends
  • 4.6. Value Chain Analysis

5. Global Red Biotechnology Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • 5.3. Monoclonal Antibodies
    • 5.3.1. Global Red Biotechnology Market, by Monoclonal Antibodies, by Region, 2020-2034 (USD Billion)
  • 5.4. Polyclonal Antibodies
    • 5.4.1. Global Red Biotechnology Market, by Polyclonal Antibodies, by Region, 2020-2034 (USD Billion)
  • 5.5. Recombinant Proteins
    • 5.5.1. Global Red Biotechnology Market, by Recombinant Proteins, by Region, 2020-2034 (USD Billion)
  • 5.6. Vaccines
    • 5.6.1. Global Red Biotechnology Market, by Vaccines, by Region, 2020-2034 (USD Billion)
  • 5.7. Cell-Based Immunotherapy Products
    • 5.7.1. Global Red Biotechnology Market, by Cell-Based Immunotherapy Products, by Region, 2020-2034 (USD Billion)
  • 5.8. Gene Therapy Products
    • 5.8.1. Global Red Biotechnology Market, by Gene Therapy Products, by Region, 2020-2034 (USD Billion)
  • 5.9. Cell Therapy Products
    • 5.9.1. Global Red Biotechnology Market, by Cell Therapy Products, by Region, 2020-2034 (USD Billion)
  • 5.10. Tissue-Engineered Products
    • 5.10.1. Global Red Biotechnology Market, by Tissue-Engineered Products, by Region, 2020-2034 (USD Billion)
  • 5.11. Stem Cells
    • 5.11.1. Global Red Biotechnology Market, by Stem Cells, by Region, 2020-2034 (USD Billion)
  • 5.12. Cell Culture
    • 5.12.1. Global Red Biotechnology Market, by Cell Culture, by Region, 2020-2034 (USD Billion)
  • 5.13. Viral Vector
    • 5.13.1. Global Red Biotechnology Market, by Viral Vector, by Region, 2020-2034 (USD Billion)
  • 5.14. Enzymes
    • 5.14.1. Global Red Biotechnology Market, by Enzymes, by Region, 2020-2034 (USD Billion)
  • 5.15. Kits and Reagents
    • 5.15.1. Global Red Biotechnology Market, by Kits and Reagents, by Region, 2020-2034 (USD Billion)
  • 5.16. Animal Models
    • 5.16.1. Global Red Biotechnology Market, by Animal Models, by Region, 2020-2034 (USD Billion)
  • 5.17. Molecular Diagnostics
    • 5.17.1. Global Red Biotechnology Market, by Molecular Diagnostics, by Region, 2020-2034 (USD Billion)
  • 5.18. Others
    • 5.18.1. Global Red Biotechnology Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Red Biotechnology Market, by End Use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • 6.3. Academic Research Institutes
    • 6.3.1. Global Red Biotechnology Market, by Academic Research Institutes, by Region, 2020-2034 (USD Billion)
  • 6.4. CMOs & CROs
    • 6.4.1. Global Red Biotechnology Market, by CMOs & CROs, by Region, 2020-2034 (USD Billion)
  • 6.5. Pharmaceutical & Biotechnology Companies
    • 6.5.1. Global Red Biotechnology Market, by Pharmaceutical & Biotechnology Companies, by Region, 2020-2034 (USD Billion)
  • 6.6. Others
    • 6.6.1. Global Red Biotechnology Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Red Biotechnology Market, by Geography

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Red Biotechnology Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 7.3. Red Biotechnology Market - North America
    • 7.3.1. North America: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
    • 7.3.2. North America: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.3.3. Red Biotechnology Market - U.S.
      • 7.3.3.1. U.S.: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.3.3.2. U.S.: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.3.4. Red Biotechnology Market - Canada
      • 7.3.4.1. Canada: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.3.4.2. Canada: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • 7.4. Red Biotechnology Market - Europe
    • 7.4.1. Europe: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
    • 7.4.2. Europe: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.3. Red Biotechnology Market - UK
      • 7.4.3.1. UK: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.4.3.2. UK: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.4. Red Biotechnology Market - France
      • 7.4.4.1. France: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.4.4.2. France: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.5. Red Biotechnology Market - Germany
      • 7.4.5.1. Germany: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.4.5.2. Germany: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.6. Red Biotechnology Market - Italy
      • 7.4.6.1. Italy: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.4.6.2. Italy: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.7. Red Biotechnology Market - Spain
      • 7.4.7.1. Spain: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.4.7.2. Spain: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.8. Red Biotechnology Market - Netherlands
      • 7.4.8.1. Netherlands: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.4.8.2. Netherlands: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.9. Red Biotechnology Market - Russia
      • 7.4.9.1. Russia: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.4.9.2. Russia: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.10. Red Biotechnology Market - Rest of Europe
      • 7.4.10.1. Rest of Europe: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.4.10.2. Rest of Europe: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • 7.5. Red Biotechnology Market - Asia Pacific
    • 7.5.1. Asia Pacific: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
    • 7.5.2. Asia Pacific: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.3. Red Biotechnology Market - China
      • 7.5.3.1. China: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.5.3.2. China: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.4. Red Biotechnology Market - India
      • 7.5.4.1. India: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.5.4.2. India: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.5. Red Biotechnology Market - Malaysia
      • 7.5.5.1. Malaysia: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.5.5.2. Malaysia: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.6. Red Biotechnology Market - Japan
      • 7.5.6.1. Japan: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.5.6.2. Japan: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.7. Red Biotechnology Market - Indonesia
      • 7.5.7.1. Indonesia: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.5.7.2. Indonesia: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.8. Red Biotechnology Market - South Korea
      • 7.5.8.1. South Korea: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.5.8.2. South Korea: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.9. Red Biotechnology Market - Australia
      • 7.5.9.1. Australia: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.5.9.2. Australia: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.10. Red Biotechnology Market - Rest of Asia Pacific
      • 7.5.10.1. Rest of Asia Pacific: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.5.10.2. Rest of Asia Pacific: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • 7.6. Red Biotechnology Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
    • 7.6.2. Middle East & Africa: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.6.3. Red Biotechnology Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.6.4. Red Biotechnology Market - UAE
      • 7.6.4.1. UAE: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.6.4.2. UAE: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.6.5. Red Biotechnology Market - Israel
      • 7.6.5.1. Israel: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.6.5.2. Israel: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.6.6. Red Biotechnology Market - South Africa
      • 7.6.6.1. South Africa: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.6.6.2. South Africa: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.6.7. Red Biotechnology Market - Rest of Middle East & Africa
      • 7.6.7.1. Rest of Middle East & Africa: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.6.7.2. Rest of Middle East & Africa: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • 7.7. Red Biotechnology Market - Latin America
    • 7.7.1. Latin America: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
    • 7.7.2. Latin America: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.7.3. Red Biotechnology Market - Mexico
      • 7.7.3.1. Mexico: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.7.3.2. Mexico: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.7.4. Red Biotechnology Market - Brazil
      • 7.7.4.1. Brazil: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.7.4.2. Brazil: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.7.5. Red Biotechnology Market - Argentina
      • 7.7.5.1. Argentina: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.7.5.2. Argentina: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.7.6. Red Biotechnology Market - Rest of Latin America
      • 7.7.6.1. Rest of Latin America: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.7.6.2. Rest of Latin America: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. AstraZeneca
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Amgen Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Merck & Co
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Bristol-Myers Squibb
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Pfizer
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Biogen
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. F. Hoffmann-La Roche Ltd
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Gilead Sciences, Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. MavriX Bio
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Regeneron Pharmaceuticals, Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Takeda Pharmaceutical Company
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development

List of Tables:

  • Table 1 Global Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 2 Global Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 3 North America: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 4 North America: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 5 U.S.: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 6 U.S.: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 7 Canada: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 8 Canada: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 9 Europe: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 10 Europe: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 11 UK: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 12 UK: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 13 France: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 14 France: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 15 Germany: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 16 Germany: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 17 Italy: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 18 Italy: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 19 Spain: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 20 Spain: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 21 Netherlands: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 22 Netherlands: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 23 Russia: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 24 Russia: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 25 Rest of Europe: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 26 Rest of Europe: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 27 Asia Pacific: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 28 Asia Pacific: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 29 China: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 30 China: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 31 India: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 32 India: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 33 Malaysia: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 34 Malaysia: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 35 Japan: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 36 Japan: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 37 Indonesia: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 38 Indonesia: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 39 South Korea: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 40 South Korea: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 41 Australia: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 42 Australia: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 43 Rest of Asia Pacific: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 44 Rest of Asia Pacific: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 45 Middle East & Africa: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 46 Middle East & Africa: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 47 Saudi Arabia: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 48 Saudi Arabia: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 49 UAE: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 50 UAE: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 51 Israel: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 52 Israel: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 53 South Africa: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 54 South Africa: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 55 Rest of Middle East & Africa: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 56 Rest of Middle East & Africa: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 57 Latin America: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 58 Latin America: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 59 Mexico: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 60 Mexico: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 61 Brazil: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 62 Brazil: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 63 Argentina: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 64 Argentina: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 65 Rest of Latin America: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 66 Rest of Latin America: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Red Biotechnology Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Red Biotechnology Market, by Product, 2024 & 2034 (USD Billion)
  • Figure 8. Market by End Use
  • Figure 9. Global Red Biotechnology Market, by End Use, 2024 & 2034 (USD Billion)